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Introduction
The analysis of the specialized literature reveals that 
many issues regarding differential treatment of epilepsy re-
quire subsequent clarification. As far as we are concerned, 
we have designed and developed therapeutic recommen-
dations, in our opinion, effective, supporting the results of 
treating epilepsy in its various stages, from premonition 
to status variants. In this context, the main element in the 
choice of preparations, besides the trivial clinical signs, was 
the use of sub-curative monitoring data, including repeated 
EEG examinations, which fixed the subjective response of 
patients. Choosing the best possible medicine or an opti-
mal combination of medicines is sometimes difficult. The 
perfect antiepileptic should be long, nonsedative, well tol-
erated, very active in various types of convulsive and with 
non-harmful effects on vital organs and functions. In addi-
tion, it must be effective in various forms of active epilepsy 
and in treating underlying epileptic seizures and capable of 
restoring the electroencephalogram between seizures to its 
normal form [5; 9; 10; 18; 23; 24; 27; 31; 38; 40; 41; 43].
It is still debatable whether such a drug will ever be 
discovered, and especially one that will control all types of 
epilepsy. The thorough study of pharmacological properties 
allows us to appreciate which of the existing antiepileptics 
will meet the current requirements of our patients under 
study. Due to the fact that patients differ considerably after 
clinical response to known anticonvulsants and the possi-
bilities of treatment with associated drugs are insufficiently 
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Abstract
Background: Pharmacological management of patients with epilepsy is still a very challenging approach for the best outcome of these patients. When 
considering the appropriate treatment choice for patients it is necessary to take into account several factors that can influence the effectiveness and quality 
of life. Cancelling or changing treatment suddenly can lead to uncontrolled seizures. After a short period without seizures, many patients are tempted to 
abandon treatment. Cessation of treatment can be discussed after a seizure-free period for at least two years. Treatment should be discontinued gradually 
by reducing the dosage and constant supervision of the physician. This paper analyses briefly the general pharmacological and treatment methods in 
several forms of adult epilepsy.
Conclusions: Management of epilepsy means more than observing the medication prescribed by the specialist. It is also important for the patient to 
maintain his general health status, monitor the symptoms of epilepsy and response to treatment and take care of his safety. Involvement in the management 
of one’s own affection can help the patient to control his condition and to continue his routine in usual manner. The objective of antiepileptic treatment 
is to reduce epileptic seizures to zero without intolerable side effects. New treatments should focus not only on reducing the frequency and intensity of 
seizures but also improving the quality of life of patients.
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and superficially researched, testing of more efficient sub-
stances including new combinations continues. Due to the 
modern medication, which benefits from a wide and suffi-
ciently efficient range of specific drugs, a large proportion of 
the recurrent and the disabling sequelae of the disease can 
be prevented. The adverse effects of drugs are low, so many 
of the past patients who have been labelled for life by this 
suffering can now live a productive life. The actual ability 
to control this disease effectively prevents more of its severe 
consequences [12; 13; 15; 22; 29; 46; 50].
General principles of pharmacotherapy  
of epilepsies
In the treatment of psychiatric disorders of our patients 
with epilepsy we have taken into account the following prin-
ciples:
Appropriate selection of the remedy, its dosing, routes of 
administration and possible side effects. And we took into 
account the following:
1. The syndrome of psychic state – the gradual expres-
sion of the disorders, the relationship between productive 
and negative alterations and the type of impairment of psy-
chic processes.
2. The dynamic characteristics of the psychic state – the 
duration of the disturbances, the changes in the presence of 
paroxysmal manifestations.
3. The somatic and neurological condition of the patient 
with epilepsy. This parameter is important in the context 
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of the evidence of side effects of favorable and unfavorable 
preparations. Somatic mood dictates and the route of ad-
ministration of drugs: parenteral in gastrointestinal disor-
ders, endonasal or transorbital (by electrophoresis) when 
parenteral administration is not preferred.
Individual features of the patient with epilepsy (age, 
weight, response to anticonvulsant therapy and others) are 
also considered. It is often forgotten that lower doses are 
indicated for children and older people as the exchange of 
substances in them is slow and standard dose treatment 
leads to accumulation of preparations and adverse effects 
[6; 7; 14; 19].
We recommend the gradual increase of the doses, with 
the preference of the minimal effective doses of the drugs. 
All the above-described drugs are initially indicated at min-
imal doses, then the dose gradually increases until the first 
positive effects are displayed, the subsequent increase of the 
doses is made after a certain period of time to stabilize the 
positive effect.
Complex treatment – it is necessary to prescribe uni-
moment of anticonvulsant remedies from different classes 
and groups in combination with non-medication methods. 
Polipharmacologic treatment has certain priorities in com-
parison with monotherapy because it addresses different 
links of the pathological process. It is important to avoid the 
multidimensional effects of many drugs, the doubling of the 
mechanisms of action and the predilection of some and the 
same psychological processes.
Continuous therapy. The treatment of productive dis-
orders is done until their complete jugulation (sometimes 
with the purpose of preventing relapse and longer), of the 
deficient ones by alternating the cures, with gradual modifi-
cations [28; 30; 34; 39; 42].
Principles of medication of psychosomatic 
syndromes in epilepsy
Criteria for the effectiveness of psychotropic remedies 
administered in epilepsy are those of improving the knowl-
edge and behavioral processes. More differentiated treat-
ment is based on syndrome of mental disorders. 
1. Deficient disorder (transient dementia, mental-mental 
diminution, etc.) The treatment is continuously practiced, 
alternating the belts. It is rational to indicate the prepara-
tions of different subgroups. The following criteria are taken 
into consideration when drawing up the treatment scheme: 
a) Main mechanism of action: nootrop, general metabo-
lism, cerebrovascular or actoprotector; 
b) Predominant action on mediating processes: GABA 
(piracetam, fenibut, gamma-aminobutyric acid); cholin-
ergic (gliatiline); dopaminergic (nakom); and combined 
(meclofenoxate, glycine, glutamic acid); 
c) With predominant action on the function of the en-
cephalic structures: the cerebral and subcortical (nakom), 
on the left hemisphere (gliatilline); on the right hemisphere 
(cortexil);
d) With action on psychomotor activity: major stimu-
lation (piracetam, nakom vinpocetine), mean enhance-
ment (aminalone, gamma-aminobutyric acid, cerebrolizine, 
nicergoline, tanakan), diminishment (fenibut, glycine, ci-
narizine); 
e) Route of administration: parenteral, internal, endo-
nasal, transorbital (by electrophoresis), mixed. Duration of 
treatment: from 7 days to 4 months (nakom, fenibut). On 
the basis of this therapy it is also possible to indicate pro-
phylactic doses of anticonvulsants.
2. For different types of excitation (chaotic, twilight, de-
lusional, manic, psychopathic, etc.) the support treatment 
are the sedative neuroleptics. Major tranquilizers, barbitu-
rates and other anticonvulsants, may also be indicated seda-
tive antidepressants.
3. Hallucinatory delusions. More rational are antipsy-
chotic neuroleptics. In the case of neuroleptic syndrome 
with caution are added corrective remedies. That adjuvant 
preparations use daytime tranquilizers, in depressive or 
anxious states are used antidepressants.
4. Emotional productive disruptions. In the states of ex-
citation are indicated predominantly sedative neuroleptics 
and tranquilizers, antidepressants – in depression, tranqui-
lizers and antiepileptics – in dysphoria, in anxiety states – 
neuroleptics and tranquilizers.
5. Productive districts nearby. Psychoparticular depres-
sions are typically treated with “inor” euroleptics, prefer-
ably “behavioral correctors” or low doses of risperidone and 
tranquilizers; in neurotic manifestations (asthenia, obses-
sions, hysteria, hypocondria) are used tranquilizers and low 
doses of antidepressants [1; 2; 3; 4; 8; 11; 25; 26].
Complex epilepsy medication programs
Over the past decades has been made a remarkable 
progress in assisting epilepsies. In most cases, however, 
treatment of epilepsy is symptomatic since it is known that 
only the treatment can prevent recurrences that often result 
from the action of noxes chronic epileptogenes when it be-
comes necessary to correct some metabolic disorders in the 
brain lesions. Etiological is also the specific anti-infectious 
treatment in the case of epileptic-generating neuroinfec-
tions. The antiepileptic treatment performed in newly ex-
amined patients aims to control crises and ensure a social 
life that is close to normal. This treatment was based on the 
use of last-minute anticonvulsants (carbamazepine, sodium 
valproate, phenobarbital, diazepam, apaurine, phenytoin), 
which in most cases have more or less pronounced side 
effects. They were adapted by us to the form of epilepsy, 
evolutionary gravity and individual tolerance. The general 
principles of treatment of epilepsy were in selecting the 
optimal preparation depending on the type of epileptic sei-
zures, selecting the optimal dose, usually minimal, which 
allows plenary control of epileptic seizures. The treatment 
prescribed by us must be lengthy and uninterrupted. How-
ever, the optimal duration of specific treatment is purely in-
dividual for each patient with epilepsy, as opposed to the 
complete cessation of crises, which ranged from 6 months 
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to 5 years. Sometimes, depending on the type of epileptic 
seizures, the medication was indicated lifelong. Interrup-
tion of treatment was performed gradually for 3-8 months 
with clinical and electroencephalographic monitoring. We 
have also been very careful in avoiding the factors that trig-
ger epileptic and cautious seizures in observing the optimal 
life regime [17; 20; 21; 32; 33; 44].
Antiepileptic treatment divides into:
• Emergency (juggling of crises);
• Long-term treatment (crisis prevention);
• Etiological treatment.
The medical treatment of epilepsies should represent as 
far as possible a monotherapy. The drug selection is based 
on the type of epilepsy. In generalized seizures and partial 
seizures that have been reported in our patients, we ex-
amined the use of new carbamazepine, sodium valproate, 
phenobarbital. At patients with petit mal absence, the elec-
tive drug we administered was sodium valproate. In the 
category of patients with epileptic encephalopathy in the 
treatment we have prescribed sodium valproate and corti-
coids that have given good results. Some treatment failures, 
marked by the repeating crises, originally focused on the 
idea of whether it was correctly applied. In this regard, it is 
useful to determine the serum concentration of the drug. 
If the serum level of the drug is satisfactory, but the crises 
are repeated, the change in treatment by administering or 
associating the second antiepileptic should be called into 
question. Continuing treatment is essential, and the sudden 
abolition of specific medication increases the risk of the cri-
sis. The basic principle that we recommend following our 
examinations of patients with epilepsy over several years for 
the treatment of epileptic seizures is one of the highest ur-
gency, which has two essential components, namely:
• Anticonvulsants for stopping epileptic seizure as soon 
as possible.
• Secondary measures, but of vital importance: Mainte-
nance in resuscitation and intensive care units. In the case 
of the 259 patients with epilepsy, we found that (58.7%) 
received stable care, (41.3%) were outpatients. They were 
hospitalized repeatedly – (19%) of patients. When using 
an anticonvulsant in maximum therapeutic doses with the 
occurrence of adverse events, it is reasonable to reduce the 
dose slightly and to associate other anticonvulsants with the 
summary of the effects of the preparations. Thus, their po-
tential became known in various combinations, therefore 
in their prescription requires a thorough dynamic control 
of the functional status of the kidneys, liver and peripheral 
blood.
The basic principle of the therapy is complex treatment, 
based on a strict evidence of the structural features of 
paroxysms and the clinical evolution of the disorder in 
both in onset and in different stages. The analysis of the 
therapeutic measures has demonstrated that the most 
effective in benign sleep epilepsy are those with minimal 
hypnotic effect and with tropism predilection for subcortical 
formations (finlepsin, diphenin, chloracon, hexamedine, 
sodium tetraborate, elenium).
In patients with epilepsy, whose seizures throughout 
the full illness are produced in sleep with the hours of peak 
during the first half of the night; the drug is usually given half 
an hour before bedtime. 
Thus, it has fallen definitively the need to administer in 
three divided doses of anti-epileptic drugs in patients with 
epilepsy, even more so that the effect was obtained with 
a single dose. Therefore, the medication possesses the 











The application of treatment of the patient with epilepsy 
is carried out in three steps:
1) Preferential drug choice;
2) Obtaining therapeutic remission, strengthening, pre-
vention of worsening and patient behavior without seizures 
for a period of 3-5 years;
3) The suspension of treatment according to the lack of 
clinical manifestations and EEG of epilepsy [18; 26; 49].
Treatment in ambulatory conditions
Controlling seizures caused by epilepsy requires the daily 
schedule of treatment recommended by the psychiatrist.
Antiepileptic drugs should be administered according to 
the prescription without any deviation from it. Disregarding 
the treatment scheme is one of the main reasons for the inef-
ficiency of control over the seizures.
Antiepileptic drugs are effective only when the level 
of concentration of drugs in serum is kept constant. The 
doctor is in view of this fact, recommending a specific 
scheme for each drug (a specific dosage, a certain scheme of 
administration, etc.). Not administering a dose compromises 
the whole treatment. The same rule applies and in the case 
of patients with epilepsy who follow a cetogenic diet (the 
complete exclusion of fats and protein) recommended by 
the physician to improve the control of the drug-resistant 
epilepsy. Cetogenic diet can be difficult to follow it, but it is 
mandatory to respect it.
In addition to medical treatment, the physician rec-
ommends identifying and avoiding situations, conditions 
which determine the occurrence of seizures, such as [16; 17; 
25; 28; 47]:
• Drinking alcoholic beverages;
• Drinking beverages or foods that contain caffeine;
• Drug use;
• Emotional stress;
• Excessive sun exposure;
• Lack of adequate sleep;
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• Prolonged use of computers;
• Reducing the number of daily meals;
• Watching TV for several hours.
Epilepsy medication
The drugs used to prevent seizures are called antiepilep-
tics. The goal consists in finding effective anti-epileptic medi-
cation which may lead to the least adverse effects. The ef-
ficiency of antiepileptics in the prevention of seizures is 60–
70%. Although many people suffer the side effects of these 
drugs, this is the best way to prevent convulsions. The ben-
efits usually outweigh the shortcomings of these medicines.
There are many types of anti-epileptic drugs (also called 
anticonvulsants), but not all of them treat the same type of 
seizures. The first step in the choice of anticonvulsants is the 
correct diagnosis of the type of epilepsy and seizures that 
the patient with epilepsy produces. It may take more time to 
find the best combination of drugs, by adjusting the doses, 
by testing multiple drugs. The goal is to prevent seizures 
with adverse effects as low as possible.
Once it has been found the most effective treatment, it 
is very important for the patient to follow the physician’s 
recommendations. Monotherapy (single drug use) is 
strongly recommended as the treatment of first intention.
Monotherapy causes fewer side effects and does not have 
the risk of interacting with other drugs. Also, the chances of 
forgetting or mistaking the time of drug administration are 
much lower in the monotherapy compared to a multi-drug 
treatment.
When monotherapy is ineffective, adding a second 
medication can improve seizure control. Also, in the case of 
patients with multiple types of seizures, it needs more than 
a single drug [2; 3; 4; 17; 28; 45].
Interaction with other drugs. Most antiepileptic rem-
edies do not induce side effects, but there are exceptions. 
Therefore, always carefully read the information in the leaf-
let. Some medications, for example those based on medici-
nal plants are not accompanied by adequate information. In 
such situations, consult with your doctor.
Timetable schedule. Since the effect of most antiepileptic 
drugs is of short duration, they must be administered daily 
at the same time, according to doctor’s recommendations. 
Administration of medicines before or after meals does not 
affect the efficiency.
It is very important that the antiepileptic drug to be 
taken regularly to maintain its blood concentration at a 
relatively constant level. If for any reasons you have not 
taken the drug according to the prescriptions, consult with 
your doctor. However, there is no standard solution for such 
situations because other factors are involved, such as the 
type of anti-epileptic drug, the dosage and any other drug 
that you take that may affect the disease or the treatment 
that it is followed.
Pregnancy and breast-feeding. If you are planning to 
have a baby, consult with your doctor to ensure that your 
health allows this, that the disease is under control and that 
your future baby will be born healthy. Ideally, you should 
consult with a medical specialist and with a gynecologist to 
discuss antiepileptic treatment during pregnancy.
Epilepsy is not a contraindication to breast-feeding. Al-
though the drug delivery mechanisms are not fully deve-
loped in the newborn, and anti-epileptics received through 
milk may be stored in the body, it may be breast-fed if close-
ly monitored and treated in the long term.
Cessation of antiepileptic medication. Since anti-
epileptic drugs control only the excessive electrical activity 
of the brain and do not cure it, the treatment should be 
followed for an indefinite term. The sudden cessation of the 
treatment or changing it can result in uncontrolled seizures. 
After a short period without seizures, many patients are 
tempted to abandon the treatment. Practice has shown that 
the cessation of treatment can be discussed after a seizure-
free period of at least two years. Treatment will cease 
gradually, by constant dose reduction and mandatory under 
the supervision of the attending physician [19; 24; 25; 27; 
31; 37; 49].
Tips for minimizing the occurrence of seizures among 
epileptics [4; 9; 13; 15; 36]:
• Know your triggers and try to avoid them
• Avoid drugs and alcohol
• Have a regular sleep schedule
• Eat a healthy diet
• Minimize factors in your life that cause stress
• Find a competent physician and follow his instructions
• Do not ever feel weird if you call your doctor to ask 
questions about your health.
• Take your anti-seizure medication as prescribed.
• Do not skip your anti-seizure medication and do not 
stop taking it abruptly. 
• If the doctor is too busy, the nurse will help you.
• Ask your doctor before taking any other medicines.
• If you have an allergy, do not start taking antihista-
mines before getting your doctor's approval, especially if 
you have not taken antihistamines before.
• Educate yourself. Read everything you can about sei-
zures and treatment.
Tips for increasing safety around the house, and how to 
feel more confident about going out:
• If you suffer from seizures, wear a seizure-alert brace-
let (doctors will see it and know what type of treatment to 
administer)
• Carry your medical information in your wallet.
• Use plastic glasses and plates instead of glass and por-
celain.
• Put a ”usy” sign on the bathroom door, because if you 
have a crisis the door is not locked and the people can get 
to you quickly.
• If your child is suffering from seizures, place an inter-
phone in his / her room.
• If child suffers from epilepsy and sleeps overnight at a 
friend’s house, ask your child to always sleep in a low bed, 
and never use a top bunk.
• Use tightly fitted sheets
• Sleep without a pillow, or use firm pillows.
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• Put emergency telephone numbers and first aid in-
structions on the refrigerator. 
• Beware of tobacco, avoiding the risk of a fire.
• Install smoke alarms.
• Minimize sharp edges and corners
• Carpet the floors with thick under-padding
• Put barriers in front of hot stoves or fireplaces
• Swim with a friend.
• Never swim alone.
• Keep the water level in the tub as low as possible, to 
avoid drowning in the event of a seizure.
• Do not drive until permitted by law and your physician
• Knowledge is power.
• The more you learn about epilepsy, the more you can 
deal with your illness.
Responding to seizures. First aid during seizures
An epileptic seizure or seizure attack can be scary. A 
convulsive crisis temporarily interferes with muscle control, 
movement, speech, vision, or consciousness. It can cause 
violent shaking of a person’s entire body for a few seconds 
or minutes, accompanied by loss of consciousness [7; 12].
Convulsions can be mild or severe and affect patients dif-
ferently. Even if people feel helpless when they are around a 
patient who has convulsions and is difficult to look at, there 
are many things they can do to help [8; 14; 35] 
If you see someone having a seizure, you can do the fol-
lowing: 
• Keep yourself and others calm;
• Protect the person from injuries;
• Protect from falls if possible;
• Move furniture or other objects that could harm the 
person during the crisis;
• Do not insert anything, including fingers, into the pa-
tient's mouth
The person responding and performing first aid can be 
bitten, to minimize the risk, you can do the following [9; 
11; 19]:
• Turn the patient to one side, with the mouth down (if 
it can be moved).
• Do not try to keep the patient lying down.
After a seizure:
• Examine whether the person has suffered injuries.
• Turn the patient to one side during convulsions, do this 
after the crisis has ended and the individual is more relaxed.
• Clean the mouth and remove vomit, if the patient has 
dyspnea (difficulty breathing).
• Choose a safe area where the patient can be seated to 
rest.
• Do not let the person eat or drink until completely 
aware.
• Survey the patient until he/she is aware and familiar 
with the surroundings.
Precious information can be provided to the treating 
physician about the person experiencing a seizure disorder. 
Remember and inform the doctor about these features:
• Way of movement of the patient's body
• Duration of seizures
• Behavior of the patient before the attack
• Patient's behavior immediately after convulsions
• If the individual has suffered a lesion during the seizure
Convulsions do not always require urgent medical atten-
tion. However, call emergency services immediately if one 
or more of these are true:
– The seizure happens in water;
– The person has never experienced a seizure before;
– The person who has experienced a seizure has breath-
lessness (apnea) for more than 30 seconds;
– The seizure is longer than 5 minutes (the patient may 
have a life-threatening condition);
– In case of prolonged convulsions, called epileptic sta-
tus (more than one seizure occurs within one hour);
– The person who has had a seizure disorder does not 
normally react within one hour after seizures (abolished re-
flexes, diminished attention or the patient is not completely 
awake; confusion, nausea or vomiting, dizziness; inability to 
walk or sit down; fever).
– Seizures occur after the patient complains of sud-
den headache; following signs of vascular accident such as 
speech disorder (dyslexia) or speech impairment; visual dis-
turbances; inability to move different body segments to one 
side (apraxes) [22; 29; 30; 34; 45; 48].
– The person has other health conditions like diabetes 
or heart disease.
– The person is pregnant.
Conclusions
Management of epilepsy means more than observing the 
medication prescribed by the specialist. It is also important 
for the patient to maintain his general health status, moni-
tor the symptoms of epilepsy and response to treatment and 
take care of his safety. Involvement in the management of 
one’s own affection can help the patient to control his con-
dition and to continue his routine in usual manner. The 
objective of antiepileptic treatment is to reduce epileptic 
seizures to zero without intolerable side effects. New treat-
ments should focus not only on reducing the frequency and 
intensity of seizures but also improving the quality of life of 
patients.
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